UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gut microbiome and its role in colorectal cancer

BMC cancer, 2021-12, Vol.21 (1), p.1325-1325, Article 1325

Rebersek, Martina

2021

Volltextzugriff (PDF)

Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision

Radiology and oncology, 2020-05, Vol.54 (3), p.272-277

Rebersek, Martina

2020

Volltextzugriff (PDF)

The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1st line treatment of metastatic colorectal (mCRC) patients with RAS wild-type tumour (wtRAS) – a real- life data report 2013–2018

Radiology and oncology, 2023-03, Vol.57 (1), p.103-110

2023

Volltextzugriff (PDF)

Determination of copper and other trace elements in serum samples from patients with biliary tract cancers: prospective noninterventional nonrandomized clinical study protocol

Radiology and oncology, 2024-03, Vol.58 (2), p.300-310

2024

Volltextzugriff (PDF)

Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial

BMC cancer, 2009-04, Vol.9 (1), p.120-120, Article 120

2009

Volltextzugriff (PDF)

Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients

Radiology and oncology, 2019-03, Vol.53 (1), p.85-95

2019

Volltextzugriff (PDF)

Retrospective analysis of treatment-naive Slovenian patients with metastatic melanoma treated with pembrolizumab – real-world experience

Radiology and oncology, 2020-01, Vol.54 (1), p.119-127

2020

Volltextzugriff (PDF)

Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma

Radiology and oncology, 2018-04, Vol.52 (3), p.289-295

2018

Volltextzugriff (PDF)

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience

Radiology and oncology, 2015-03, Vol.49 (1), p.80-85

2015

Volltextzugriff (PDF)

Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer

American journal of clinical oncology, 2012-06, Vol.35 (3), p.237-241

2012

Volltextzugriff (PDF)

Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study

European journal of nuclear medicine and molecular imaging, 2022-05, Vol.49 (6), p.1857-1869

2022

Volltextzugriff (PDF)

Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience

Radiology and oncology, 2016-06, Vol.50 (2), p.226-231

2016

Volltextzugriff (PDF)

The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1 st line treatment of metastatic colorectal (mCRC) patients with RAS wild-type tumour (wt RAS ) - a real- life data report 2013-2018

Radiology and oncology, 2023-03, Vol.57 (1), p.103-110

2023

Volltextzugriff (PDF)

KRAS, NRAS and BRAF mutational status and first line treatment patterns in Slovenian population with metastatic colorectal carcinoma: Five year results

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15546-e15546

2021

Volltextzugriff (PDF)

Treatment of BRAF-mutated metastatic melanoma patients with targeted therapy combinations or immunotherapy in real world setting

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21630-e21630

2018

Volltextzugriff (PDF)

Patients with metastatic melanoma treated with vemurafenib as monotherapy or in combination with cobimetinib

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e21016-e21016

2017

Volltextzugriff (PDF)

Treatment with vemurafenib in patients with metastatic melanoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e21028-e21028

2016

Volltextzugriff (PDF)

Vemurafenib in patients with metastatic malignant melanoma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e20121-e20121

2015

Volltextzugriff (PDF)

Recommendations from the Institute of Oncology Ljubljana for the treatment of patients with small bowell adenocarcinoma

Onkologija, 2021-12, Vol.25 (2)

2021

Volltextzugriff (PDF)

Management of cutaneous side effects of cetuximab therapy with vitamin K1 crème

Radiology and oncology, 2008-12, Vol.42 (4), p.215

2008

Volltextzugriff (PDF)

Recommendations for the treatment of patients with esophageal cancer and esophagogastric junction

Onkologija, 2022-12, Vol.26 (2)

2022

Volltextzugriff (PDF)

Continous treatment with bevacizumab in patients with metastatic colorectal cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e14642-e14642

2014

Volltextzugriff (PDF)

Bevacizumab-Containing Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer

Annals of oncology, 2014-06, Vol.25, p.ii89-ii89

2014

Volltextzugriff (PDF)

Integrativna onkologija

Onkologija, 2019-12, Vol.23 (2)

Martina Reberšek

2019

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(55)

Sprache

Englisch
(30)
Slowenisch
(25)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Oncology
(22)
Science & Technology
(22)
Radiology, Nuclear Medicine & Medical Imaging
(11)
Colorectal Cancer
(10)
Humans
(9)
Sistemsko Zdravljenje
(7)
Biomarkers
(6)
Male
(6)
Female
(5)
Metastases
(5)
Metastasis
(5)
Metastatic Colorectal Cancer
(5)
Middle Aged
(5)
Patients
(5)
Recommendations
(5)
Aged
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Bevacizumab
(4)
Chemotherapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Gut microbiome and its role in colorectal cancer

Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision

The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1st line treatment of metastatic colorectal (mCRC) patients with RAS wild-type tumour (wtRAS) – a real- life data report 2013–2018

Determination of copper and other trace elements in serum samples from patients with biliary tract cancers: prospective noninterventional nonrandomized clinical study protocol

Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial

Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients

Retrospective analysis of treatment-naive Slovenian patients with metastatic melanoma treated with pembrolizumab – real-world experience

Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience

Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer

Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study

Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience

The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1 st line treatment of metastatic colorectal (mCRC) patients with RAS wild-type tumour (wt RAS ) - a real- life data report 2013-2018

KRAS, NRAS and BRAF mutational status and first line treatment patterns in Slovenian population with metastatic colorectal carcinoma: Five year results

Treatment of BRAF-mutated metastatic melanoma patients with targeted therapy combinations or immunotherapy in real world setting

Patients with metastatic melanoma treated with vemurafenib as monotherapy or in combination with cobimetinib

Treatment with vemurafenib in patients with metastatic melanoma

Vemurafenib in patients with metastatic malignant melanoma

Recommendations from the Institute of Oncology Ljubljana for the treatment of patients with small bowell adenocarcinoma

Management of cutaneous side effects of cetuximab therapy with vitamin K1 crème

Recommendations for the treatment of patients with esophageal cancer and esophagogastric junction

Continous treatment with bevacizumab in patients with metastatic colorectal cancer

Bevacizumab-Containing Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer

Recommendations from the Institute of Oncology Ljubljana for the treatment of patients with gastric cancer

Integrativna onkologija

Suchergebnisse filtern